|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,533 GBX | +2.12% |
|
+1.76% | +5.61% |
| 05:11pm | European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading | MT |
| 10:20am | EU court criticizes Commission over handling of COVID vaccine contracts | RE |
By Christian Moess Laursen
GSK said it has bought Aiolos Bio, a biopharmaceutical company focused on patients with respiratory and inflammatory conditions, for an upfront consideration of $1.0 billion, with the potential for an additional $400 million.
Write to Christian Moess Laursen at christian.moess@wsj.com
(END) Dow Jones Newswires
01-09-24 0224ET
| 1st Jan change | Capi. | |
|---|---|---|
| +5.61% | 7.93TCr | |
| +57.23% | 85TCr | |
| +31.64% | 63TCr | |
| -0.72% | 36TCr | |
| +15.01% | 32TCr | |
| +12.41% | 30TCr | |
| +15.09% | 24TCr | |
| +16.76% | 23TCr | |
| +15.87% | 18TCr | |
| +4.03% | 17TCr |
GSK PLC 
